Expert Pitch

University of Utah S.J. Quinney College of Law collaborates on proposal to allow 2020 grads to waive bar exam amid COVID-19 concerns

University of Utah
10-Apr-2020 5:15 PM EDT, by University of Utah

New law graduates would be able to practice law without passing the bar exam if a new proposal by the Utah Supreme Court takes effect in the wake of the COVID-19 pandemic.

The University of Utah S.J. Quinney College of Law served a key collaborator in the proposal, unveiled by the Utah Supreme Court on April 9. Utah is among the first states in the nation to address how to handle bar exams for the Class of 2020 as COVID-19 continues to cast uncertainty on the future.

In a proposed Order for Temporary Amendments to the Bar Admissions Procedures During the COVID-19 Outbreak, the Utah Supreme Court suggests qualifying graduates will not be required to take the bar examination, but will instead be allowed to begin practicing immediately after meeting other requirements for admission. Among other requirements, applicants must complete 360 hours of post-graduate supervised practice under the guidance of a licensed and experienced Utah attorney. You can see the Court’s proposed order, reasons for the order, and comment section here: https://www.utcourts.gov/utc/rules-comment/.

 

University of Utah S.J. Quinney College of Law Dean Elizabeth Kronk Warner and Professor Louisa Heiny  provided research and insight into the court’s proposal. Both are available for media interviews to discuss the proposal, what it could mean for 2020 graduates and the historic shift taking place in legal education due to COVID-19. Kronk Warner and Heiny can address whether measures taken in Utah may be adopted in other parts of the country also grappling with how to proceed with bar examinations this summer.

 Dean Kronk Warner and Professor Heiny are available via phone, Zoom, Skype or email. 

 




Filters close

Showing results

110 of 2539
Released: 13-Jul-2020 4:05 PM EDT
OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available
Organization for Associate Degree Nursing (OADN)

OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available

Newswise: Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Released: 13-Jul-2020 3:45 PM EDT
Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Hackensack Meridian Health

The mechanisms of action of acalabrutinib led to the hypothesis it might be effective in reducing the massive inflammatory response seen severe forms of COVID19. Indeed, it did provide clinical benefit in a small group of patients by reducing their inflammatory parameters and improving their oxygenation.

Newswise: National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Released: 13-Jul-2020 3:40 PM EDT
National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Department of Energy, Office of Science

To focus its efforts against the COVID-19 pandemic, DOE is bringing the national laboratories together into the National Virtual Biotechnology Laboratory.

Newswise: Key Insights from Swedish Casino that Remained Open During COVID-19
Released: 13-Jul-2020 3:40 PM EDT
Key Insights from Swedish Casino that Remained Open During COVID-19
University of Nevada, Las Vegas (UNLV)

As casinos in Las Vegas enter the second month of reopening since the COVID-19 pandemic took hold, UNLV gaming researchers say they can draw upon insights from industry collaborators in Sweden, a country that took a more open approach to the crisis compared to other governments.

Released: 13-Jul-2020 3:05 PM EDT
Asymptomatic Transmission and Reinfection of COVID: Live Event for July 16, 2PM EDT
Newswise

Emerging data shows more risk of asymptomatic transmission and reinfection with COVID than previously thought. Experts will discuss these findings and what are the implications for managing the pandemic. Media are invited to attend and ask questions.

Released: 13-Jul-2020 2:40 PM EDT
Engineered llama antibodies neutralize COVID-19 virus
Rosalind Franklin Institute

Antibodies derived from llamas have been shown to neutralise the SARS-CoV-2 virus in lab tests, UK researchers announced today.

Released: 13-Jul-2020 1:25 PM EDT
1 in 3 young adults may face severe COVID-19
University of California, San Francisco (UCSF)

As the number of young adults infected with the coronavirus surges throughout the nation, a new study by researchers at UCSF Benioff Children's Hospitals indicates that youth may not shield people from serious disease.

Released: 13-Jul-2020 12:25 PM EDT
Scientists discover key element of strong antibody response to COVID-19
Scripps Research Institute

A team led by scientists at Scripps Research has discovered a common molecular feature found in many of the human antibodies that neutralize SARS-CoV-2, the coronavirus that causes COVID-19.

Released: 13-Jul-2020 11:15 AM EDT
UTHealth joins study of blood pressure medication’s effect on improving COVID-19 outcomes
University of Texas Health Science Center at Houston

An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is underway at Memorial Hermann and Harris Health System’s Lyndon B. Johnson Hospital.


Showing results

110 of 2539

close
3.75746